[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"survey-and-questionnaire\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:survey-and-questionnaire":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,46,81,107],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":21,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":29,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":45},"100601425","characteristics-of-persistent-pain-composition-following-total-hip-or-knee-arthroplasty-a-descriptive-study-100601425",false,"NCT07110324","Characteristics of Persistent Pain Composition Following Total Hip or Knee Arthroplasty: a Descriptive Study","PAIN-COMPO","Inclusion Criteria:\n\n* All patients with persistent moderate-severe pain (NRS\\>3) after THA, TKA and UKA\n* Acceptance to be contacted.\n\nExclusion Criteria:\n\n* Re-operation\n* Luxation\n* Do not want to be contacted\n* Post-operative complications such as prosthesis infection, thromboembolism or fracture of the prosthesis.","ALL","18 Years",{"count":19,"type":20},100,"ESTIMATED","1 Year","OBSERVATIONAL","Despite high success rates of hip and knee arthroplasty, up to 20% of patients report moderate-to-severe pain (NRS \\> 3) persisting beyond the expected healing period. This investigator-initiated, descriptive cohort study will re-invite approximately 100 consenting patients with persistent postoperative pain-identified from a pool of \\~7 000 respondents-to complete standardized assessments of neuropathic (DN4), nociplastic (IASP criteria + Fibromyalgia Survey Questionnaire) and nociceptive (KOOS\u002FHOOS pain domains) pain. Primary outcomes are the prevalence of potential nociplastic pain and the proportion experiencing significant pain in two or more mechanistic categories. Secondary analyses will compare baseline vs. re-evaluated DN4 scores, FSQ and KOOS\u002FHOOS distributions, and examine differences between patients with and without possible neuropathic pain. Findings will inform targeted pre- and postoperative pain management strategies.",[25,26,27,28],"Pain (Visceral, Somatic, or Neuropathic)","Hip Arthroplasty Replacement","Knee Arthroplasty, Total","Survey and Questionnaire",[30,31,32],"Pain","hip arthroplasty","knee arthroplasty","RECRUITING","2026-03-31",{"date":36,"type":37},"2026-04-01","ACTUAL",{"date":39,"type":37},"2025-06-26",{"date":41,"type":20},"2026-12-01",{"name":43,"class":44},"Rigshospitalet, Denmark","OTHER",1,{"id":47,"slug":48,"hasResults":11,"nctId":49,"briefTitle":50,"officialTitle":50,"acronym":51,"eligibilityCriteria":52,"healthyVolunteers":53,"sex":16,"minAge":54,"maxAge":55,"enrollmentInfo":56,"targetDuration":4,"studyType":58,"phases":59,"briefSummary":61,"conditions":62,"keywords":64,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":80},"100569614","exploring-participant-preference-for-screening-methods-and-experience-into-colorectal-cancer-screening-programme-100569614","NCT06696534","Exploring Participant Preference for Screening Methods and Experience Into Colorectal Cancer Screening Programme","MS-Care","Inclusion Criteria:\n\n* Participants ages from 50 to 69 years (both included) at the time of informed consent signed.\n* Participants invited to participate in population-based screening programme who are eligible to undertake FOBT at the Primary Health Care Center.\n* Participants should sign an informed consent. They must understand the nature, significance, implications, and risks of the clinical study before signing the informed consent form.\n\nExclusion Criteria:\n\n* Participants who have not delivery a stool sample in the Primary Health Care Center before signing the informed consent form.\n* Participants with a previous colonoscopy in consequence of a FOBT positive result.\n* Participants who are in a dependent personal or non-medical relationship with the Sponsor or the Investigators.",true,"50 Years","69 Years",{"count":57,"type":20},1000,"INTERVENTIONAL",[60],"NA","The goal of this low-risk interventional study is to analyze participants' assessment of colorectal cancer screening program through screening method preference and experience after FOBT analysis in screaned participant population for colorectal cancer; could include any of the following: both sexes, age 50-69 years, asympthomatic volunteers. The main aims to answer are:\n\n* Values of experience of participants into screening programme.\n* Values of preferences of participants for screening methods.\n\nParticipants will answer two questionnaires and they'll be given their information and clinical data to investigator or health personnel.",[63,28],"Screening for Colon Cancer",[65,66,67,68,69],"colorectal cancer","screening programme","experience","preference","questionnaire","2025-09-29",{"date":72,"type":37},"2025-10-02",{"date":74,"type":37},"2025-05-19",{"date":76,"type":20},"2025-12",{"name":78,"class":79},"ADVANCED MARKER DISCOVERY S.L.","INDUSTRY",2,{"id":82,"slug":83,"hasResults":11,"nctId":84,"briefTitle":85,"officialTitle":85,"acronym":86,"eligibilityCriteria":87,"healthyVolunteers":53,"sex":16,"minAge":54,"maxAge":55,"enrollmentInfo":88,"targetDuration":4,"studyType":58,"phases":90,"briefSummary":91,"conditions":92,"keywords":97,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":100,"lastUpdatePostDateStruct":101,"startDateStruct":103,"completionDateStruct":105,"leadSponsor":106,"locationsCount":80},"100570160","evaluation-of-prevecols-efficiency-as-a-second-line-method-for-the-early-colorectal-cancer-detection-100570160","NCT06703632","Evaluation of PreveCol's Efficiency As a Second Line Method for the Early Colorectal Cancer Detection","MS-Prevecol","Inclusion Criteria:\n\n* Participants ages from 50 to 69 years (both included) at the time of informed consent signed.\n* Participants should sign an informed consent. They must understand the nature, significance, implications, and risks of the clinical study before signing the informed consent form.\n* Participants with a positive result of FIT\u002FFOBT analysis referred to the gastroenterology department who are eligible to undertake colonoscopy as a regular procedure of the colorectal cancer screening programme.\n* Participants asymptomatic, average risk for CRC. Average risk is defined as those individuals who are age 50 or over with no history of adenoma, colorectal cancer, or inflammatory bowel disease, and with no family history of CRC (first degree relatives).\n\nExclusion Criteria:\n\n* Participants who have developed any another type of cancer in the 5 years prior to their participation in the study.\n* Participants who have previously received chemotherapy or radiotherapy (5 years).\n* Participants previously or currently diagnosed with Familiar Adenomatous Polyposis or Lynch Syndrome or Inflammatory Bowel Disease.\n* Inadequate intestinal preparation for colonoscopy with BBPS score ≤1 in any colon section, excluding diagnostic of CRC.\n* Participants who have undergone polypectomy in the previous 5 years.\n* Hemolysis of blood sample or absence of blood sample.\n* Participants who are arrested at judicial or official request\n* Participants who are in a dependent personal or non-medical relationship with the Sponsor or the investigator.",{"count":89,"type":20},4538,[60],"The objective of this low-risk interventional study is to evaluate whether the PreveCol® test has sufficient efficiency to be considered as a second-line method for the detection of both colorectal cancer and advanced adenomas when used prospectively in the screening population with a previous positive FOBT result, which could include any of the following: both sexes, age 50-69 years, asympthomatic volunteers. The main aims to be answered are:\n\n* Values of efficacy, efficiency, impact and safety of PreveCol.\n* Values of preferences of participants for screening methods.\n* Values of PREMs into screening programme.\n\nParticipants will provide a blood sample prior to a screening colonoscopy, and complete two questionnaires. They will give their sample, information and clinical data to the investigator or health care personnel.",[63,93,28,94,95,96],"Blood Samples","Colorectal Carcinoma","Colon Adenocarcinoma","Precancerous Lesion of Colon",[65,66,98,99,69],"liquid biopsy","second line","2025-02-25",{"date":102,"type":37},"2025-02-27",{"date":104,"type":37},"2025-01-14",{"date":76,"type":20},{"name":78,"class":79},{"id":108,"slug":109,"hasResults":11,"nctId":110,"briefTitle":111,"officialTitle":111,"acronym":4,"eligibilityCriteria":112,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":113,"targetDuration":115,"studyType":22,"phases":4,"briefSummary":116,"conditions":117,"keywords":121,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":124,"lastUpdatePostDateStruct":125,"startDateStruct":127,"completionDateStruct":129,"leadSponsor":131,"locationsCount":45},"100560793","evaluation-of-validity-and-reliability-of-the-turkish-translation-of-the-digital-health-readiness-questionaire-in-different-chronic-diseases-100560793","NCT06581770","Evaluation of Validity and Reliability of the Turkish Translation of the Digital Health Readiness Questionaire in Different Chronic Diseases","Inclusion Criteria:\n\n* The study will include people over the age of 18, native Turkish speakers, literate, obese, diabetic, cardiovascular and respiratory patients.\n\nExclusion Criteria:\n\n* Individuals with insufficient cooperation (Mini Mental Test score \\<24) and any cognitive problems that may prevent the administration of the survey will be excluded from the study.",{"count":114,"type":20},200,"2 Months","The World Health Organization (WHO) defines digital health as the field of knowledge and application related to any aspect of the adoption of digital technology in the stages of improvement. The combination of digital health with technology brings about a new transformation in digital media. This transformation allows for the development of communication and information in health services, the ability to conduct health-related research on digital media and the evaluation of this data. The ease of access to information and the provision of a timely feedback mechanism in the face of problems have enabled the spread of digital health systems, and have also enabled chronic disease management and epidemic disease monitoring.\n\nIt is recommended that the term digital readiness be used to cover the combination of digital access and use, digital literacy and digital health literacy. Digital health readiness is also defined as the main determinant of health and is thought to contribute to the improvement of health processes with the development of digital health literacy and to be a useful solution against health problems that may arise in the follow-up of chronic diseases.\n\nAlthough there are tools in the literature that evaluate digital health readiness, there is no Turkish assessment tool that facilitates the follow-up of non-communicable chronic diseases. Therefore, the aim of our study is to evaluate the translation, validity, and reliability of the Digital Health Readiness Questionaire into Turkish in individuals with chronic non-infectious diseases.",[118,28,119,120],"Non-Communicable Chronic Diseases","Validation Studies","Digital Health",[122,123],"digital health","Digital Health Readiness Questionaire","2025-02-05",{"date":126,"type":37},"2025-02-10",{"date":128,"type":37},"2024-10-15",{"date":130,"type":20},"2025-09-15",{"name":132,"class":44},"Istanbul Galata University"]